Cardiac endpoints in older adults: a closer look
A brief guide to the 2026 bimagrumab cardiac study, its population and the limits of interpreting safety endpoints.
Read the research briefResearch notes
Beyond the headline.
Short, source-linked briefs to help you read bimagrumab research with the right context.
Bimagrumab and semaglutide in the BELIEVE trial
Understand the BELIEVE phase 2 study design and how to read combination-therapy research without confusing clinical evidence with reagent specifications.
Read the research brief
The 2021 body composition trial, revisited
Revisit an early phase 2 bimagrumab study and learn why study completion, endpoint definitions and published corrections matter.
Read the research briefDates shown are the source publication dates. Briefs were prepared and sources reviewed on 8 October 2026. Updates are editorially reviewed; this is not a live news feed.